Inicio › Cáncer de próstata › Washington
Ensayos clínicos de Cáncer de próstata en Washington
51 estudios sobre Cáncer de próstata buscan participantes en Washington.
Ciudades en Washington
- Seattle42 estudios
- Tacoma11 estudios
- Spokane Valley9 estudios
- Spokane6 estudios
- Kirkland5 estudios
- Bellingham5 estudios
- Renton5 estudios
- Everett4 estudios
- Walla Walla4 estudios
- Vancouver4 estudios
- Kennewick4 estudios
- Longview4 estudios
Texto oficial del estudio (inglés)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Washington, Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- y 19 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Valley Medical Center, Renton
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Swedish Medical Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 28 sept 2026 · NCT06095089Precision-Based Genomics in Prostate Cancer
- University of Washington, Seattle
ReclutandoEstudio observacional
Edades de 18 a 120 · Hombres · Actualizado el 28 sept 2026 · NCT04706663Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutchinson Cancer Research Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 25 sept 2026 · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Spokane Urology ( Site 0035), Spokane
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06136650A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 25 sept 2026 · NCT07082920This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Northwest Medical Specialties, PLLC, Bonney Lake
- Northwest Medical Specialties, PLLC, Federal Way
- Northwest Medical Specialties, PLLC, Gig Harbor
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 24 sept 2026 · NCT07028853Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Fred Hutchinson Cancer Research Center, Seattle
ReclutandoFase 2/3
Edades de 18 a 100 · Hombres · Actualizado el 22 sept 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Northwest Medical Specialties, PLLC, Tacoma
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 22 sept 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Swedish Medical Center, Seattle
- Northwest Medical Specialties, Tacoma
ReclutandoFase 3
Edades de 18 a 100 · Hombres · Actualizado el 22 sept 2026 · NCT06855277High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- VA Puget Sound Health Care System ( Site 0054), Seattle
- Fred Hutchinson Cancer Center ( Site 0060), Seattle
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT06925737PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
- University of Washington Medical Center, Seattle
ReclutandoEstudio observacional
Edades de 18 en adelante · Hombres · Actualizado el 15 sept 2026 · NCT04995198The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
- University of Washington, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 14 sept 2026 · NCT06111781Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 10 sept 2026 · NCT05946213Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site Number: 400, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 10 sept 2026 · NCT05997615Prostate Active Surveillance Study
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
ReclutandoEstudio observacional
Edades de 21 en adelante · Hombres · Actualizado el 2 sept 2026 · NCT00756665The Vanguard Study: Testing a New Way to Screen for Cancer
- Madigan Army Medical Center, Tacoma
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT06995898Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 27 ago 2026 · NCT07698535AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Tacoma
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 26 ago 2026 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 25 ago 2026 · NCT05593497Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- University of Washington Medical Center, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 24 ago 2026 · NCT07745361A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 21 ago 2026 · NCT06844383Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 21 ago 2026 · NCT04221542Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- y 19 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 19 ago 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
- Northwest Medical Specialties, PLLC - Tacoma, Tacoma
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 ago 2026 · NCT06842498Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 14 ago 2026 · NCT04812366Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
ReclutandoEstudio observacional
Edades de 18 en adelante · Hombres · Actualizado el 12 ago 2026 · NCT04489719Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 11 ago 2026 · NCT06236139A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 10 ago 2026 · NCT06067841Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
ReclutandoFase 2
Todas las edades · Hombres · Actualizado el 6 ago 2026 · NCT06145633Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Hombres · Actualizado el 6 ago 2026 · NCT01050504Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 31 jul 2026 · NCT06613100Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
- Fred Hutch/University of Washington Cancer Consortium, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 21 jul 2026 · NCT06039371Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 15 jul 2026 · NCT05918263Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Providence Regional Cancer System-Aberdeen, Aberdeen
- FHCC Overlake, Bellevue
- PeaceHealth Saint Joseph Medical Center, Bellingham
- y 22 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 jul 2026 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- University of Washington, Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 9 jul 2026 · NCT05413421De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.